A Study of E2814 With Concurrent Lecanemab Treatment in Participants With Early Alzheimer's Disease
Public ClinicalTrials.gov record NCT06602258. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Placebo-Controlled, Double-Blind, Parallel-Group, Dose-Finding Study to Evaluate Safety, Tolerability, and Biomarker Efficacy of E2814 With Concurrent Lecanemab Treatment in Subjects With Early Alzheimer's Disease
Study identification
- NCT ID
- NCT06602258
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Eisai Inc.
- Industry
- Enrollment
- 105 participants
Conditions and interventions
Conditions
Interventions
- E2814 Drug
- Lecanemab Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 50 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Not listed
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 29, 2024
- Primary completion
- Dec 2, 2026
- Completion
- Aug 17, 2027
- Last update posted
- Feb 10, 2026
2024 – 2027
United States locations
- U.S. sites
- 18
- U.S. states
- 10
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Banner Sun Health Research | Phoenix | Arizona | 85006 | — |
| Yale University School of Medicine | New Haven | Connecticut | 06510 | — |
| Bradenton Research Center | Bradenton | Florida | 34205 | — |
| K2 Medical Research | Clermont | Florida | 34711 | — |
| Advanced Clinical Research Network | Miami | Florida | 33165 | — |
| Renstar Medical Research | Ocala | Florida | 34470 | — |
| Progressive Medical Research | Port Orange | Florida | 32124 | — |
| Alzheimer's Research and Treatment Center-Stuart | Stuart | Florida | 34997 | — |
| Axiom Brain Health | Tampa | Florida | 33609 | — |
| Charter Research | The Villages | Florida | 32162 | — |
| Alzheimer's Research and Treatment Center | Wellington | Florida | 33467 | — |
| Columbus Memory Center, PC | Columbus | Georgia | 31909 | — |
| Hattiesburg Clinic | Hattiesburg | Mississippi | 39401 | — |
| Washington University School of Medicine | St Louis | Missouri | 63110 | — |
| Abington Neurological Associates LTD | Abington | Pennsylvania | 19001 | — |
| Neurology Clinic, P.C. | Cordova | Tennessee | 38018 | — |
| Kerwin Memory Center | Dallas | Texas | 75231 | — |
| National Clinical Research-Richmond, Inc | Richmond | Virginia | 23294 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 8 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06602258, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 10, 2026 · Synced Apr 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06602258 live on ClinicalTrials.gov.